Insulin resistance in polycystic ovary syndrome

被引:5
|
作者
Schröder, AK
Tauchert, S
Ortmann, O
Diedrich, K
Weiss, JM
机构
[1] Univ Klinikum Schleswig Hostein, Klin Frauenheilkunde & Geburtshilfe, D-23538 Lubeck, Germany
[2] Univ Klinikum Regensburg, Caritas Krankenhaus St Josef, Klin Frauenheilkunde & Geburtshilfe, Regensburg, Germany
关键词
polycystic ovary syndrome; PCOS; insulin resistance; diabetes mellitus; cardiovascular risk; risks; IMPAIRED GLUCOSE-TOLERANCE; TYPE-2; DIABETES-MELLITUS; GROWTH-FACTOR-I; METFORMIN THERAPY; OBESE WOMEN; CARDIOVASCULAR-DISEASE; RISK-FACTORS; YOUNG-WOMEN; LIFE-STYLE; PREVALENCE;
D O I
10.1007/BF03041041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With a prevalence of 5-10% the polycystic ovary syndrome (PCOS) is a common disorder of premenopausal women. According to prospective studies abnormal glucose tolerance and diabetes mellitus present in about 10.0% and 35.0% of adult women with PCOS, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension and dyslipidaemia. The rate of spontaneous abortions as well as the risk of developing gestational diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem, but a complex endocrine disease with important health implications. The role of glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.
引用
收藏
页码:812 / 821
页数:10
相关论文
共 50 条
  • [41] Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance
    Bethea, S. W.
    Nestler, J. E.
    PANMINERVA MEDICA, 2008, 50 (04) : 295 - 304
  • [42] Insulin resistance and lipid metabolism in polycystic ovary syndrome
    Falsetti, L
    Gambera, A
    Andrico, S
    Bugari, G
    RECENT RESEARCH IN GYNECOLOGICAL ENDOCRINOLOGY, 2001, : 27 - 30
  • [43] Insulin Resistance and Polycystic Ovary Syndrome Through Life
    Diamanti-Kandarakis, Evanthia
    Spritzer, Poli Mara
    Sir-Petermann, Teresa
    Beatriz Motta, Alicia
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (34) : 5569 - 5576
  • [44] Fetal insulin resistance and maternal polycystic ovary syndrome
    Tobiasz, Ana
    Duncan, Jose
    Mari, Giancarlo
    Detti, Laura
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (01) : S447 - S448
  • [45] Insulin Resistance and Anthropometric Parameters Polycystic Ovary Syndrome
    Memili, Seyra
    Sar, Fuat
    Memili, Vecihi
    Kazancioglu, Rumeyza
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2009, 47 (01): : 6 - 12
  • [46] Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome
    Mahmoudi, Touraj
    Gourabi, Hamid
    Ashrafi, Mahnaz
    Yazdi, Reza Salman
    Ezabadi, Zahra
    FERTILITY AND STERILITY, 2010, 93 (04) : 1208 - 1214
  • [47] Insulin Resistance and Adolescent Girls with Polycystic Ovary Syndrome
    Bhattacharya, S. M.
    Ghosh, M.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2010, 23 (03) : 158 - 161
  • [48] Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome
    Wu, XK
    Zhou, SY
    Liu, JX
    Pöllänen, P
    Sallinen, K
    Mäkinen, M
    Erkkola, R
    FERTILITY AND STERILITY, 2003, 80 (04) : 954 - 965
  • [49] Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome
    El-Mazny, Akmal
    Abou-Salem, Nermeen
    El-Sherbiny, Walid
    El-Mazny, Ahmed
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 109 (03) : 239 - 241
  • [50] Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome
    Lankarani, Mahnaz
    Valizadeh, Neda
    Heshmat, Ramin
    Peimani, Maryam
    Sohrabvand, Farnaz
    GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (08) : 504 - 507